The prevalence rate and the incidence rate of hemodialysis and functioning kidney transplant recipients have continuously increased; on the contrary, those of peritoneal dialysis have continuously decreased since 2006. Dialysis patients have been getting older and have been maintained on dialysis longer. Diabetic nephropathy was the leading cause of end stage renal disease. The type of hemodialysis vascular access has been stable during the last 5 years (arteriovenous fistulas 76%, arteriovenous grafts 16%, central venous catheters 8% at 2016). Peritoneal dialysis catheter was mostly inserted surgically (67%), and swan neck straight tip peritoneal dialysis catheter was the most commonly used (48%). Vascular access was managed by radiologists and surgeons, and the management was fragmented among them in the past. However, since the nephrologists became interested in and knowledgeable about the vascular access, they began to play roles in vascular access management. Vascular access has been mostly created by vascular surgeons (≈60%); tunneled central venous hemodialysis catheter insertion and endovascular intervention such as percutaneous transluminal angioplasty (PTA) and thrombectomy have been mostly performed by radiologists (≈70%). Tunneled hemodialysis catheter insertion and endovascular intervention by nephrologists have slowly but consistently increased. Recently, the number of central venous hemodialysis catheter insertion has decreased, and tunneled hemodialysis catheter has been inserted more than non-tunneled hemodialysis catheter, indicating that vascular access has been created timely and the vascular access team has been educated about and following international guidelines.
Characteristics of renal replacement therapy
End stage renal disease (ESRD) registry data at the end of 2016 have been reported by ESRD registry committee of the Korean Society of Nephrology (KSN). 1, 2 The total number of patients with renal replacement therapy (RRT) was 93,884 (hemodialysis (HD) 68,853, peritoneal dialysis (PD) 6,842, and kidney transplant (KT) 18,189). The number of HD and KT patients has continuously increased. On the contrary, the number of PD patients has continuously declined since 2006 (Figure 1(a) ). As the population of Korea at the end of 2016 was 51,696,216, the prevalence rate of RRT was 1,816 patients per million population (pmp). The proportion of RRT was HD 73%, PD 7%, and KT 19%, and the proportion of dialysis was HD 91% and PD 9%. The number of new RRT patients was 16,068 (HD 13,049, PD 786, KT 2, 233) . Out of 2,233 KTs, there were 901 (40.3%) deceased donors. The incidence rate of RRT was 311 pmp. The trend of annual change in the incidence rate was similar as the prevalence rate (Figure 1(b) ).
There were 24,115 HD machines in 896 dialysis centers. Mean number of HD machines in a center was 27. Mean age of dialysis patients has continuously increased, and it was 61.2 ± 14.5 years old (HD, 62.3 ± 14.2 years old; PD, 53.8 ± 14.6 years old). According to the three major causes of ESRD (diabetes mellitus, hypertension, and chronic glomerulonephritis), diabetic patients were the oldest (63.4 ± 12.4 years old), and the chronic glomerulonephritis patients were the youngest (55.6 ± 14.8 years old) ( Figure  2 ). The proportion of elderly dialysis patients, which was defined as ⩾65 years old, was 43.9%. Duration of dialysis therapy has also increased. Patients on chronic HD >5 years accounted for 45% (>10 years, 18%), and patients on PD >5 years accounted for 47% (>10 years, 14%).
The most common primary cause of ESRD was diabetic nephropathy (50.2%), and the next causes were hypertensive nephrosclerosis (20.3%) and chronic glomerulonephritis (8.4%) (Figure 3 ).
In summary, while the prevalence rate and the incidence rate of HD and KT have continuously increased, those of PD have continuously decreased since 2006. Dialysis patients have been getting older and have been maintained on dialysis longer. Diabetic nephropathy was the leading cause of ESRD.
Characteristics of dialysis access
According to ESRD registry data at the end of 2016, the types of HD vascular access was arteriovenous fistula (AVF) 76%, arteriovenous graft (AVG) 16%, and central venous catheter (CVC) 8%. The proportion of the three types of HD vascular access has been stable during the last 5 years. Location of AVF and AVG was left forearm 59%, left upper arm 25%, right forearm 11%, or right upper arm 5%.
Surgical insertion was the most common (67%) method for PD catheter insertion. The next method was blind insertion using trocar with various modifications. Fluoroscopic insertion was performed in a couple of centers. The most common type of PD catheter was swan neck (curved subcutaneous segment) straight tip PD catheter 48%, then, straight subcutaneous segment straight tip PD catheter 23%, straight subcutaneous segment coiled tip PD catheter 19%, swan neck coiled tip PD catheter 5%, and others 5%. 
Characteristics of HD vascular access management in the past
In the past until 2009, characteristically, vascular access management has been extremely fragmented among radiologists and surgeons; on the contrary, nephrologists played little role. Vascular access creation and surgical revision of dysfunctional or complicated vascular access have been carried out by surgeons, and radiologists have been in charge of endovascular interventions for dysfunctional vascular access. In contrast, nephrologists were totally dependent on them in terms of the vascular access care. When there was a patient with dysfunctional or thrombosed vascular access, a nephrologist referred the patient to a surgeon or a radiologist, and the treatment plan was made by a surgeon or a radiologist. On the contrary, from their point of view, vascular access intervention was not their first priority and was a minor part of their works. Therefore, during the patient referring process, the treatment was often delayed, which might need CVC insertion for immediate HD, lose vascular access or need hospitalization. Furthermore, decision makings of the treatment plan by a single doctor was not always correct, which sometimes resulted in unacceptable outcome after the interventional procedure. Conclusively, dysfunctional or complicated vascular access was not timely and adequately managed in the past.
Establishment of interventional nephrology
Nephrologists know the most about the dialysis patients including primary renal disease and comorbidities, are experts in HD, and have the best understanding of how the vascular access impacts the patient's care. Therefore, nephrologists must play a leading role in the multidisciplinary team of vascular access care.
However, nephrologists were not knowledgeable about vascular access, because neither medical resident nor nephrology fellowship training programs dealt with vascular access. In consequence, dialysis patients have been cared by nephrologists with no vascular access experience and by surgeons or radiologists with no dialysis experience. With this system of care, vascular access problems have increased, and this fact led nephrologists to be interested in vascular access. However, the opportunity to start an interventional nephrology program was very limited because of the turf issues between departments and lack of support from organizations or from senior nephrologists.
The most striking recent change was the establishment of interventional nephrology that enabled nephrologists to play roles in the vascular access management. Some nephrologists who were trained in the vascular access interventional procedures and who were aspiring interventional nephrologists gathered and made a study group for interventional nephrology in July 2010, which developed to Korean Society of Diagnostic and Interventional Nephrology (KSDIN) on 2013.
The study group and KSDIN have focused on educating nephrologists and dialysis nurses. For nephrologists, educational programs regarding vascular access, such as halfday programs every 3 months and a full-day program including hands-on session a year, were provided by KSDIN. The KSN included a similar symposium and a half-day hands-on session in the scientific programs of the annual meeting. Several university hospitals also provided educational programs of vascular access. Similar numbers of educational programs for dialysis nurses were available during the last 8 years. KSDIN had regular Dialysis Access Symposium with Japanese doctors from 2011 eight times in order to share knowledge and experiences. Short-term or long-term training programs in interventional nephrology were available for national and international young nephrologists in a vascular access center in Seoul, Korea.
Performance of interventional procedures
KSDIN annually surveyed 72 university hospitals about which department was responsible for the interventional procedures since 2011. AVF or AVG has been created by vascular surgeons (≈60%), chest surgeons (≈30%), and other surgeons (≈10%), which was not different during the last 6 years. Non-tunneled HD catheter insertion to central vein or femoral vein has been mostly performed by nephrologists (nephrologists 62%, radiologists 33%, surgeons 5% at 2017). Ultrasound was used in 65% of cases, and fluoroscopy was used in 20% of cases. Central vein tunneled HD catheter insertion has been mostly performed by radiologists (radiologists 70%, nephrologists 18%, surgeons 9%, others 3% at 2017). Ultrasound and fluoroscopy were used in 90% of cases. Endovascular procedures such as percutaneous transluminal angioplasty (PTA) and thrombectomy were mostly performed by radiologists (radiologists 68%, surgeons 22%, nephrologists 7%, others 3% at 2017). The PD catheter has been mostly inserted by surgeons (surgeons 78%, nephrologists 19%, radiologists 3%). The role of nephrologists in the tunneled HD catheter insertion and endovascular procedures has slowly but consistently increased (Table 1) . Kidney biopsy has been mostly performed by nephrologists (nephrologists 50%, radiologists 34%, nephrologist and radiologist together 16% in 2017), showing most remarkable progress in the role of nephrologists (radiologists 43%, nephrologists 26%, nephrologist and radiologist together 31% in 2010).
Insurance system and quality assessment of dialysis center
We have a unique insurance system operated by the National Health Insurance Service (NHIS). The NHIS serves as the insurer, decides the cost of all interventional procedures, and makes the reimbursement policies based on the assessment of Health Insurance Review & Assessment Service (HIRA), which conducts reviews and assessment of medical fees. The NHIS is overseen by the Ministry of Health and Welfare (MOHW).
Medical insurance is a national obligation. In general, a dialysis patient pays 10% and NHIS pays 90% of all medical cost including interventional procedures. Some lowincome dialysis patients are exempt from 10% payment of medical cost. Medical fees for interventional procedures seem to be quite low. AVF creation costs $658, AVG creation $640, AVF or AVG angiography $345, PTA $1,050, mechanical thrombectomy $1,141, tunneled HD catheter insertion with fluoroscopy $152, and high pressure balloon catheter $215-$250.
Medical costs of interventional procedures are generally reimbursed by NHIS. For PTA and uncovered stent insertion, reimbursement is decided after HIRA reviews and assessment of the reasonability of the procedures. However, covered stent is not reimbursed yet.
The HIRA in collaboration with KSN began to assess quality of dialysis center based on the 18 parameters (12 parameters from 2017) in 2009 and graded the centers from 1 (best quality) to 5 (unacceptable quality). The grade of each center is freely open to patients through the homepage of HIRA. The current 12 parameters include proportion of KSN certified dialysis specialists in HD unit, number of HD treatments/doctor/day, proportion of experienced nurses (working in HD unit >2 years), number of HD treatments/nurse/day, number of HD machines isolated to HBsAg(+) patients, presence of emergency kit in HD unit, frequency of water test, frequency of dialysis adequacy test, frequency of routine laboratory test, frequency of vascular access surveillance, proportion of patients with adequate dialysis dose according to KT/ Vurea, and proportion of patients with adequate Ca × P levels. For vascular access surveillance, static intraaccess pressure ratio (SIAPR) or access flow measurement (either by ultrasound dilution technique or by duplex doppler ultrasound) is recommended. Currently, SIAPR is the most common vascular access surveillance (80%); access flow measurement by ultrasound dilution technique is the next (15%). Duplex doppler ultrasound is used in small number of the centers because it is much more expensive than ultrasound dilution technique. The execution rate of vascular access surveillance was 80% in 2009, and it was 96% in 2013.
Changing trend in interventional procedures
According to HIRA data from 2010 to 2016, the number of CVC insertion for HD has continuously increased. In 2016, 17,961 CVCs for HD were inserted in 15,592 patients. However, the number of patients for whom CVCs were inserted for HD decreased by 13.4% per 1,000 HD patients (261.5 in 2010, 226.5 in 2016). The number of CVC insertions for HD per 1,000 HD patients has also decreased by 14.1% (303.8 in 2010, 260.9 in 2016) ( Figure  4) . Furthermore, while the number of non-tunneled catheters was much more than the number of tunneled catheters in 2010 (non-tunneled 7,825 vs tunneled 4,177), it was reversed from 2012 (non-tunneled 6,721 vs tunneled 11,240 in 2016) ( Figure 5 ). These results indicate that vascular access has been created timely, and vascular access team has been educated about and following international guidelines. The number of vascular access PTA has rapidly increased, which was approximately 6,000 cases in 2010, and 23,000 cases in 2017. 
Discussion
Since medical insurance is a mandatory obligation and it covers the part of medical fee of all national population in 1989, the number of dialysis patients (both HD and PD) has rapidly increased. The reason for declining PD penetration after 2006 seems to be multifactorial. One major reason that may explain the declining PD penetration is very low profit for dialysis center compared with profit from HD. Due to smaller number of PD patients, medical residents or nephrology fellows are less exposed to PD patients; consequently, they do not receive adequate training to have confidence in their ability to care for PD patients. As a result, young nephrologists prefer HD treatment. Similar situation of low PD penetration has been reported in other countries. 3, 4 A survey by KSDIN showed PD catheter has been mostly inserted by surgeons, and it has been inserted by nephrologists only in 19% of the centers. This fact might contribute to the low PD penetration. Interestingly, mean number of the PD patients in centers where nephrologist inserted the PD catheter was significantly higher than that where the surgeon inserted the PD catheter (165 patients vs 77 patients). It has been shown that PD catheter insertion by nephrologists promoted the growth of PD. 5, 6 Centers where nephrologists inserted tunneled HD catheter increased 11% (from 7% to 18%), and centers where nephrologists performed endovascular intervention increased only 5% (from 2% to 7%) during the last 6 years. One major obstacle to the rapid growth of interventional nephrology seems that senior nephrologists lack knowledge and interest in vascular access, and they do not support young nephrologists aspiring to be interventionalists. Turf issues among departments are another major obstacle to start the interventional nephrology program. Recently, HD vascular access center was founded in some centers. The team includes nephrologists, surgeons, radiologists, nurses, technicians, and vascular access coordinators. A multidisciplinary approach to HD access is known to reduce complications of access intervention, decrease hospitalization, save medical cost, and increase the rate of AVF creation. 7-9 
